PMID- 19658448 OWN - NLM STAT- MEDLINE DCOM- 20091013 LR - 20090807 IS - 1175-0561 (Print) IS - 1175-0561 (Linking) VI - 10 IP - 5 DP - 2009 TI - Intravenous immunoglobulin-induced, non-eczematous, vesiculobullous eruptions in Stevens-Johnson syndrome. PG - 339-42 LID - 10.2165/11310610-000000000-00000 [doi] AB - Intravenous immunoglobulin (IVIG) has emerged as a promising treatment that interrupts the progression of Stevens-Johnson syndrome (SJS). Our patient experienced an uncommon adverse effect, non-eczematous, vesiculobullous eruptions, after treatment with IVIG. These new lesions developed rapidly on the palms while most previous SJS bullous lesions subsided. A skin biopsy of these new lesions showed an intracorneal vesicle, without epidermal necrosis, with inflammatory cell infiltration. IVIG-induced, vesiculobullous eruptions are discussed, along with their possible pathogenesis. With the increasing use of IVIG for treatment of bullous dermatoses, recognition of this rare adverse effect is important for prompt differential diagnosis. FAU - Lin, Wan-Lung AU - Lin WL AD - Department of Dermatology, Chang Gung Memorial Hospital, Taipei, Taiwan. FAU - Lin, Wen-Chi AU - Lin WC FAU - Chang, Ya-Ching AU - Chang YC FAU - Yang, Li-Cheng AU - Yang LC FAU - Hung, Shuen-Iu AU - Hung SI FAU - Hong, Hong-Shang AU - Hong HS FAU - Chung, Wen-Hung AU - Chung WH LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - New Zealand TA - Am J Clin Dermatol JT - American journal of clinical dermatology JID - 100895290 RN - 0 (Immunoglobulins, Intravenous) RN - 0 (Immunologic Factors) SB - IM MH - Biopsy MH - Diagnosis, Differential MH - Female MH - Hand Dermatoses/chemically induced/diagnosis MH - Humans MH - Immunoglobulins, Intravenous/*adverse effects/therapeutic use MH - Immunologic Factors/adverse effects/therapeutic use MH - Middle Aged MH - Skin Diseases, Vesiculobullous/*chemically induced/diagnosis MH - Stevens-Johnson Syndrome/*drug therapy EDAT- 2009/08/08 09:00 MHDA- 2009/10/14 06:00 CRDT- 2009/08/08 09:00 PHST- 2009/08/08 09:00 [entrez] PHST- 2009/08/08 09:00 [pubmed] PHST- 2009/10/14 06:00 [medline] AID - 9 [pii] AID - 10.2165/11310610-000000000-00000 [doi] PST - ppublish SO - Am J Clin Dermatol. 2009;10(5):339-42. doi: 10.2165/11310610-000000000-00000.